News

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.
In the chicken-and-egg debate of who rises first, GDP growth or credit growth, we thankfully, have a new contender -- reforms, said the report by HSBC Global Investment Research ...